openPR Logo
Press release

ADULATION 3 TIMES OVER FOR CROSS-TAB

12-30-2010 10:17 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Cross-tab

Cross-Tab, a global leader in market research outsourcing, with over 450 full time employees and more than 100 clients, is proud to announce that it has been listed in some of the world’s most prestigious and accredited company rankings list for the year 2010. Cross-Tab was shortlisted in the below mentioned rankings –
• India Fast Growth 25 by All World Network
• Deloitte Technology Fast 50 India
• Deloitte Technology Fast 500 Asia Pacific 2010

Expressing his delight, Mr. Ashwin Mittal, President, Cross-Tab, said, “I attribute this success to 3 key factors - team’s hard work, our commitment to getting it right the first time and company’s continuous investment in technology to provide unmatched experience to our customers. I am also thrilled that we are among the select few companies in APAC region with the distinction of featuring in Deloitte Technology Fast 500 for the fourth year.”

About Cross Tab: Cross-Tab (www.cross-tab.com) is a market research outsourcing company that provides full range of market research and data analytics solutions to various international clients, which include Microsoft, Nielsen and Synovate among others. Its range of services include - managing end-to-end research operations, market research process outsourcing, secondary research, research analytics and online data collection.

About the Rankings:
India Fast Growth 25 is considered to list the most competitive fast growth companies in Asia Pacific as per All World’s International standards. The Award recognizes 10 high growth industries in the diverse field from the APAC region. Cross-Tab was ranked 19th in the list, which recognizes that it successfully met All World’s international criteria of size, age, performance, and sales growth between 2007 and 2009.

Michael Porter, the co-founder of the network and Board Chairman of Harvard Business School says “The India 25 companies, led by dynamic men and women, represent the leading edge of a new approach to India’s competitiveness.”

The Deloitte Technology rankings are based on percentage revenue growth over the past 3 years. The survey includes both public and private companies based in the APAC region.

Cross-Tab offers outbound CATI interviewing from India to English-, French-, German-, Russian-, and Spanish- speaking markets. Cross-Tab has wet-leased 60 seats with a well-known India based call center experienced with Market Research. This strategic call center provides the infrastructure and call associates while Cross-Tab manages the project and the training of the associates. The data collection aspect through CATI is closely monitored for both voice and data quality by separate teams specialized for the same.

11820 Northup Way,
Suite E200
Bellevue,
WA 98005
USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ADULATION 3 TIMES OVER FOR CROSS-TAB here

News-ID: 156925 • Views:

More Releases for Cross

Platelet and Plasma markets Share Trends Analysis Growth: America's Blood Center …
Rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According to American Academy of Neurology, plasma can be used for treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for treatment of conditions such as inflammatory dysimmune neuropathies, multiple
Platelet and Plasma Market 2018: Study on Top Players | America’s Blood Center …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the Study
Platelet and Plasma Market Prominent Players – America’s Blood Centers, Amer …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the
Platelet and Plasma Market : Illustrious Companies - America’s Blood Centers, …
Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report. Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in
Platelet and Plasma Market : Study on Key Players | America’s Blood Centers, A …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights.Growing number of blood transfusions globally is another impact rendering factor for the growth of platelets and plasma market. According to European commission’s 2017 annual report, more than 25 million units of blood and blood components were being issued for the purpose of transfusion in Europe. Blood
Platelet and Plasma Market : Study on Eminent Players | America’s Blood Center …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the Study